3-hydroxy-2-phenylpropanoic acid (8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl) ester has been researched along with Action Tremor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirose, H | 1 |
| Aoki, I | 1 |
| Kimura, T | 1 |
| Fujikawa, T | 1 |
| Numazawa, T | 1 |
| Sasaki, K | 1 |
| Sato, A | 1 |
| Hasegawa, T | 1 |
| Nishikibe, M | 1 |
| Mitsuya, M | 1 |
| Ohtake, N | 1 |
| Mase, T | 1 |
| Noguchi, K | 1 |
1 other study available for 3-hydroxy-2-phenylpropanoic acid (8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl) ester and Action Tremor
| Article | Year |
|---|---|
Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activity.
Topics: Animals; Benzeneacetamides; Brain; Bronchoconstriction; Heart Atria; Heart Rate; Humans; In Vitro Te | 2001 |